Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 11Sarcoma 2Plasma cell 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Other 1Gynecologic 1

Conditions

Obesity 20Mucositis 19Constipation 13Neoplasms 11Opioid-Induced Constipation 9Pain 8Overweight 6Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sexual Dysfunction, Physiological 4Bronchiolitis Obliterans Syndrome 4Xerostomia 3Stomatitis 3Radiation Injuries 3Polycystic Ovary Syndrome 3Endometrial Neoplasms 3Breast Neoplasms 3Sedentary Behavior 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Glucose Intolerance 2Dyspnea 2Chemotherapy-induced Peripheral Neuropathy 2Venous Thromboembolism 1Urinary Incontinence 1Thyroid Diseases 1Stomach Ulcer 1Stomach Neoplasms 1

Interventions

Hematologic Tests 1Echocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Cardiotoxicity × Other × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡